http://www.dicerna.com
Dicerna Pharmaceuticals, Inc. Company Intro
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company using ribonucleic acid interference (RNAi) to develop medicines that silence genes that cause disease.
Industry
Healthcare
Dicerna Pharmaceuticals, Inc. Headquaters
33 Hayden Avenue
Lexington,02421
United States
Dicerna Pharmaceuticals, Inc. Share price
22 Oct 2020 01:30 GMT
$19.20
0.08 (0.42 %)
Dicerna Pharmaceuticals, Inc. Market cap
$1.418 B
WMC RANKING
2020
Dicerna Pharmaceuticals, Inc. # 61
BiotechnologyLatest Dicerna Pharmaceuticals, Inc. News
22 Oct 2020
Liver Diseases Therapeutics Market 2020 Emergent ...
The Liver Diseases Therapeutics Market report begins with a basic overview of the ... Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc., Endo ...
22 Oct 2020
Global Liver Fibrosis Drug Market 2020 Size Share Upcoming ...
... Squibb Company, Celgene Corporation, Dicerna Pharmaceuticals Inc., Digna ... Ltd, Dr. Falk Pharma GmbH, LG Life Science LTD., Nitto Denko Corporati ...
22 Oct 2020
High Mobility Group Protein B1 Market Future Scope (2020-2027) | Competitors Analysis and Growth Factors – Ribomic Inc, Cantex Pharmaceuticals Inc, Affibody AB
Ribomic Inc, Cantex Pharmaceuticals Inc, Affibody AB, Dicerna Pharmaceuticals Inc, Evec Inc. The High Mobility Group Protein B1 report uttered an entire view ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Dicerna Pharmaceuticals, Inc. | 0.43 | 1.90 | 6.54 | 0 | 0 | 0 | 6.31 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 19 | 0 | 0 | 98.79 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 100 | 0 | 0 | 90.93 |
Dicerna Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Dicerna Pharmaceuticals, Inc. | $23,904 | $152,090 | $-120,459 | $1.418B | 61 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |